Finding the answer will depend on longitudinal natural history studies evaluating the incubation and prodromes of AD as well as its clinical progression of AD, in conjunction with PET scans done at regular intervals using p-tau and amyloid ligands. This evidence concerns the gene MAPT and Alzheimer disease.